首页> 外文学位 >The Use of HPMA Copolymer Conjugates for the Intracellular Targeting of Anticancer Drugs
【24h】

The Use of HPMA Copolymer Conjugates for the Intracellular Targeting of Anticancer Drugs

机译:HPMA共聚物结合物用于抗癌药物的细胞内靶向

获取原文
获取原文并翻译 | 示例

摘要

The work presented here represents three separate research projects. Each explores different approaches to the same problem: how can artificial macromolecules be used to target specific intracellular sites in living organisms, and how may that technology be exploited to treat different disease states? Here, the copolymers based on pHPMA [poly N-(2-hydroxypropyl)methacrylamide)] were used to demonstrate cellular and subcellular targeting in a cancer model. Used as carriers for low molecular weight drugs, pHPMA copolymers may possess great potential for increasing the efficacy of drugs, while also decreasing side effects resulting from drug exposure to healthy tissues and cells.;In the first project, antibody Fab' fragments were dimerized using a multifunctionalized PEG (poly(ethylene glycol)) crosslinker to create a targeting module for pHPMA/drug carriers. The linker was semitrifunctional, able to crosslink 2 Fab' antibody fragments, which could then be attached to an HPMA-doxorubicin anticancer drug carrier. Monoclonal antibody Fab' fragments were chosen that target ovarian carcinoma cells. Using this strategy, the conjugates are selectively uptaken by cancer cells, whereby free doxorubicin is released.;In the second project, HPMA copolymers were created with a terminal mitochondriotropic chemical moiety, TPP (triphenylphosphonium). Lipophilic cations are used to traffic low molecular weight drugs to mitochondria. Studies had reported that terminal TPP can also traffic high molecular weight, uncharged, linear macromolecules into mitochondria, and enable delivery to the cytosol via direct transduction through the plasma membrane. Semitelechelic TPP-HPMA copolymers were synthesized to determine if this effect could be applied to HPMA copolymer drug conjugates.;In the third project, the flexibility of HPMA polymerization chemistry was exploited to create a large "library" or array of different HPMA copolymers with a wide range of chemical properties. Copolymers were made incorporating a variety of cationic, anionic, and hydrophobic sidechains. This array of copolymers was incubated and microinjected directly into the cytoplasm of living cells. The resulting uptake and/or intracellular distribution was observed using time-lapse confocal microscopy and flow cytometry. Using HPMA copolymers as a model, this work functioned as a general survey for cellular uptake, and the intracellular distribution/trafficking that can be expected when artificial macromolecules are internalized into living cells.
机译:这里介绍的工作代表了三个独立的研究项目。每种方法都探讨了解决同一问题的不同方法:如何使用人造大分子靶向活生物体中特定的细胞内位点,以及如何利用该技术来治疗不同的疾病状态?在此,基于pHPMA [聚N-(2-羟丙基)甲基丙烯酰胺]的共聚物用于证明在癌症模型中的细胞和亚细胞靶向。作为低分子量药物的载体,pHPMA共聚物可能具有提高药物功效的巨大潜力,同时还减少了由于药物暴露于健康组织和细胞而导致的副作用。;在第一个项目中,抗体Fab'片段使用一种多功能的PEG(聚乙二醇)交联剂,可为pHPMA /药物载体创建靶向模块。接头是半三功能的,能够交联2个Fab'抗体片段,然后可以将其连接到HPMA-阿霉素抗癌药物载体上。选择靶向卵巢癌细胞的单克隆抗体Fab'片段。使用这种策略,缀合物被癌细胞选择性摄取,从而释放出游离的阿霉素。在第二个项目中,创建了具有末端线粒体化学部分TPP(三苯基phosph)的HPMA共聚物。亲脂性阳离子用于将低分子量药物转运至线粒体。研究已经报道,末端TPP还可以将高分子量,不带电荷的线性大分子运输到线粒体中,并可以通过质膜直接转导到细胞质中。合成了半telechechelic TPP-HPMA共聚物,以确定这种效果是否可以应用于HPMA共聚物药物共轭物。化学性质范围广。制备掺入各种阳离子,阴离子和疏水性侧链的共聚物。温育该共聚物阵列并将其直接显微注射到活细胞的细胞质中。使用延时共聚焦显微镜和流式细胞仪观察得到的摄取和/或细胞内分布。使用HPMA共聚物作为模型,这项工作可作为对细胞摄取以及将人工大分子内化到活细胞中时可以预期的细胞内分布/贩运的一般调查。

著录项

  • 作者

    Callahan, Jon Doyle.;

  • 作者单位

    The University of Utah.;

  • 授予单位 The University of Utah.;
  • 学科 Polymer chemistry.;Oncology.;Biochemistry.;Bioengineering.
  • 学位 Ph.D.
  • 年度 2017
  • 页码 231 p.
  • 总页数 231
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号